Cargando…
NAMPT inhibition sensitizes pancreatic adenocarcinoma cells to tumor-selective, PAR-independent metabolic catastrophe and cell death induced by β-lapachone
Nicotinamide phosphoribosyltransferase (NAMPT) inhibitors (e.g., FK866) target the most active pathway of NAD(+) synthesis in tumor cells, but lack tumor-selectivity for use as a single agent. Reducing NAD(+) pools by inhibiting NAMPT primed pancreatic ductal adenocarcinoma (PDA) cells for poly(ADP...
Autores principales: | Moore, Z, Chakrabarti, G, Luo, X, Ali, A, Hu, Z, Fattah, F J, Vemireddy, R, DeBerardinis, R J, Brekken, R A, Boothman, D A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669762/ https://www.ncbi.nlm.nih.gov/pubmed/25590809 http://dx.doi.org/10.1038/cddis.2014.564 |
Ejemplares similares
-
Targeting glutamine metabolism sensitizes pancreatic cancer to PARP-driven metabolic catastrophe induced by ß-lapachone
por: Chakrabarti, Gaurab, et al.
Publicado: (2015) -
Tumor-selective use of DNA base excision repair inhibition in pancreatic cancer using the NQO1 bioactivatable drug, β-lapachone
por: Chakrabarti, Gaurab, et al.
Publicado: (2015) -
Synergistic Effect of β-Lapachone and Aminooxyacetic Acid on Central Metabolism in Breast Cancer
por: Chang, Mario C., et al.
Publicado: (2022) -
MTHFD2 Blockade Enhances the Efficacy of β-Lapachone Chemotherapy With Ionizing Radiation in Head and Neck Squamous Cell Cancer
por: Shukla, Kirtikar, et al.
Publicado: (2020) -
Inhibition of TXNRD or SOD1 overcomes NRF2-mediated resistance to β-lapachone
por: Torrente, Laura, et al.
Publicado: (2020)